Lopez-Millan, B.; Costales, P.; Gutiérrez-Agüera, F.; DÃaz de la Guardia, R.; Roca-Ho, H.; Vinyoles, M.; Rubio-Gayarre, A.; Safi, R.; Castaño, J.; RomecÃn, P.A.;
et al. The Multi-Kinase Inhibitor EC-70124 Is a Promising Candidate for the Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia. Cancers 2022, 14, 1593.
https://doi.org/10.3390/cancers14061593
AMA Style
Lopez-Millan B, Costales P, Gutiérrez-Agüera F, DÃaz de la Guardia R, Roca-Ho H, Vinyoles M, Rubio-Gayarre A, Safi R, Castaño J, RomecÃn PA,
et al. The Multi-Kinase Inhibitor EC-70124 Is a Promising Candidate for the Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia. Cancers. 2022; 14(6):1593.
https://doi.org/10.3390/cancers14061593
Chicago/Turabian Style
Lopez-Millan, Belen, Paula Costales, Francisco Gutiérrez-Agüera, Rafael DÃaz de la Guardia, Heleia Roca-Ho, Meritxell Vinyoles, Alba Rubio-Gayarre, Rémi Safi, Julio Castaño, Paola Alejandra RomecÃn,
and et al. 2022. "The Multi-Kinase Inhibitor EC-70124 Is a Promising Candidate for the Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia" Cancers 14, no. 6: 1593.
https://doi.org/10.3390/cancers14061593
APA Style
Lopez-Millan, B., Costales, P., Gutiérrez-Agüera, F., DÃaz de la Guardia, R., Roca-Ho, H., Vinyoles, M., Rubio-Gayarre, A., Safi, R., Castaño, J., RomecÃn, P. A., RamÃrez-Orellana, M., Anguita, E., Jeremias, I., Zamora, L., RodrÃguez-Manzaneque, J. C., Bueno, C., MorÃs, F., & Menendez, P.
(2022). The Multi-Kinase Inhibitor EC-70124 Is a Promising Candidate for the Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia. Cancers, 14(6), 1593.
https://doi.org/10.3390/cancers14061593
